Page last updated: 2024-09-03

xaliproden and Geographic Atrophy

xaliproden has been researched along with Geographic Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, CM; Biswal, MR; Han, P; Ildefonso, CJ; Lewin, AS; Li, H	1

Other Studies

1 other study(ies) available for xaliproden and Geographic Atrophy

Article	Year
Repurposing an orally available drug for the treatment of geographic atrophy. Molecular vision, 2016, Volume: 22 Topics: Administration, Oral; Animals; Cell Line; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Repositioning; Electric Impedance; Electroretinography; Enzyme-Linked Immunosorbent Assay; Geographic Atrophy; Humans; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naphthalenes; Pyridines; Real-Time Polymerase Chain Reaction; Retina; Retinal Pigment Epithelium; Serotonin 5-HT1 Receptor Agonists; Tomography, Optical Coherence; Zonula Occludens-1 Protein	2016

Article

Year

Repurposing an orally available drug for the treatment of geographic atrophy.

Molecular vision, 2016, Volume: 22

Topics: Administration, Oral; Animals; Cell Line; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Repositioning; Electric Impedance; Electroretinography; Enzyme-Linked Immunosorbent Assay; Geographic Atrophy; Humans; Metallothionein; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naphthalenes; Pyridines; Real-Time Polymerase Chain Reaction; Retina; Retinal Pigment Epithelium; Serotonin 5-HT1 Receptor Agonists; Tomography, Optical Coherence; Zonula Occludens-1 Protein

2016